New day hospital aims to transform IBD care in a single visit

NCT ID NCT07167186

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new type of day hospital for people with inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. In one visit, patients get blood tests, a doctor checkup, education on managing their condition, and optional workshops on diet or fatigue. The goal is to see if this all-in-one approach helps patients better manage their disease and improves their care. The study will enroll 240 adults in France.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
multimodal day hospital program (combination of biological tests, gastroenterologist consultation, therapeutic education, dietary workshop, fatigue management, dermatology/rheumatology consultation, and intestinal ultrasound)
What this could lead to
If successful, this approach could improve how patients manage their IBD and help doctors tailor treatments more effectively, potentially leading to better quality of life.
What could go wrong
This is a single-center study with 240 participants, so results may not apply to all IBD patients. The benefit is measured by changes in patient skills and management, not direct disease outcomes, so it may not show clear improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service de gastroentérologie Hôpital Saint Antoine

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.